India's Dr Reddy's gets US nod for $40 generic HIV prevention shot for 120 poorer countries
Firstpost

Dr. Reddy's Laboratories announced on Monday that its generic version of
lenacapavir, an injectable drug administered twice a year, had received the US
regulator's approval




